Review Article Open Access
Volume 4 | Issue 1 | DOI: https://doi.org/10.33696/Nanotechnol.4.037
The Methods of Analysis for Determination of Metformin and Glimepiride in Different Matrices
Lobna M. Abdel-Aziz1, Ahmed S. Abdelkhalek1, Alyaa Antar1, Emad H. Abdelraziq1, Emad A. Farghaly1, Emad M. Elsayed1, Emad Y. Metwally1, Ammar Y. Khalil1, Ammar T. Khalifa1, Mahmoud M. Sebaiy1,*
- 1Medicinal Chemistry Department, Faculty of Pharmacy, Zagazig University, Sharkia, 44519, Egypt
Corresponding Author
Mahmoud M. Sebaiy, mmsebaiy@zu.edu.eg, sebaiym@gmail.com
Received Date: December 05, 2022
Accepted Date: March 21, 2023
Abdel-Aziz LM, Abdelkhalek AS, Antar A, Abdelraziq EH, Farghaly EA, Elsayed EM, et al. The Methods of Analysis for Determination of Metformin and Glimepiride in Different Matrices. J Nanotechnol Nanomaterials. 2023;4(1):1-10.
Copyright: © 2023 Abdel-Aziz LM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
In this literature review, we will introduce pharmacology in addition to most of the up-to-date reported methods that have been developed for determination of important oral hypoglycemic drugs which are metformin and glimepiride in their pure forms, combined forms with other drugs, combined forms with degradation products, and in biological samples.
Keywords
Literature review, Metformin, Glimepiride; Degradation products, Biological samples
Recommended Articles
Prospective Evaluation of Effect of Metformin on Activation of AMP-activated Protein Kinase (AMPK) and Disease Control in a Sub-group Analysis of Patients with GI Malignancies
Observational studies have demonstrated association of metformin with reduced cancer incidence and mortality in multiple cancer types, including gastrointestinal (GI) malignancies. Anti-neoplastic effects of metformin are believed through many mechanisms including activation of AMP-activated protein kinase, which controls mammalian target of rapamycin (mTOR) growth regulatory pathway.
Metformin in Patients with Chronic Heart Failure
Heart failure affects 1-2% of the adult population in developed countries and the lifetime risk of a heart failure diagnosis is 20%. Patients with heart failure have markedly reduced life expectancy, physical capacity and quality of life. One-year all-cause mortality rates for heart failure patients range between 7 and 17% and the yearly hospitalization rate can be as high as 44%.
Can Mono- or Combination Therapy of Metformin with Cimetidine and Ibuprofen be a Promising Potential Therapy for Breast Cancer?
Metformin (MET), either alone or in combination with other drugs, has been considered a promising drug in cancer therapy. MET via activation of adenosine monophosphate-activated protein kinase (AMPK) signaling pathway and inhibiting the mammalian target of rapamycin (mTOR) mediates tumor proliferation. Moreover, as an antagonist of the histamine H2-receptor (H2R), cimetidine (CIM) is also attributed to several immune-stimulatory responses in non-immunogenic cancers.
The Methods of Analysis for Determination of Metformin and Glimepiride in Different Matrices
In this literature review, we will introduce pharmacology in addition to most of the up-to-date reported methods that have been developed for determination of important oral hypoglycemic drugs which are metformin and glimepiride in their pure forms, combined forms with other drugs, combined forms with degradation products, and in biological samples.